TABLE 5.
Outcome measure | Buffer zone, m | Sex | Patients in buffer zone, n |
Unstandardized coefficients |
P | 95% CI for B | R2 | |
---|---|---|---|---|---|---|---|---|
B | SE | |||||||
FEV1 | 200 | Female | 59 | −0.17 | 0.08 | 0.029 | −0.32 to −0.02 | 0.48 |
Male | 94 | −0.02 | 0.15 | 0.911 | −0.32 to 0.28 | 0.29 | ||
FEV1 | 300 | Female | 96 | −0.16 | 0.07 | 0.036 | −0.30 to −0.01 | 0.49 |
Male | 131 | −0.18 | 0.14 | 0.203 | −0.46 to 0.10 | 0.30 | ||
VC | 200 | Female | 59 | −0.27 | 0.09 | 0.002 | −0.44 to −0.10 | 0.40 |
Male | 94 | −0.02 | 0.18 | 0.918 | −0.37 to 0.33 | 0.13 | ||
VC | 300 | Female | 96 | −0.23 | 0.08 | 0.008 | −0.39 to −0.06 | 0.39 |
Male | 131 | −0.34 | 0.16 | 0.037 | −0.66 to −0.02 | 0.15 | ||
VC, % | 200 | Female | 59 | −4.95 | 2.36 | 0.037 | −9.6 to −0.31 | 0.12 |
Male | 94 | −0.05 | 2.83 | 0.985 | −5.63 to 5.52 | 0.13 | ||
VC, % | 300 | Female | 96 | −3.52 | 2.29 | 0.125 | −8.02 to 0.99 | 0.11 |
Male | 131 | −5.4 | 2.59 | 0.037 | −10.53 to −0.33 | 0.15 | ||
FEV1, L/min (mean ± SD) | Vital capacity, L/min (mean ± SD) | Vital capacity, % (mean ± SD) | ||||||
Women | 2.1±1.1 | 2.8±1.2 | 91.4±28.7 | |||||
Men | 2.7±1.3 | 3.9±1.5 | 86.8±25.1 |
FEV1 Forced expiratory volume in 1 s